iMPI: An Integrative Database for MicroProteins Encoded by Intron Retention in Tumors
PROTEOMICS · 2026
DOI: 10.1002/pmic.70142 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS, 2026. Verfasst von Jiamin Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center f…. Hauptthemen laut MEDLINE: Introns, Neoplasms, Databases, Protein. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China, Young Talents Program of Sun Yat-sen University Cancer Center, National Natural Science Foundation of China.
Abstract (Originalsprache)
Research advancements made in the last decade have shed light on the dysregulation of cellular mechanisms that lead to aberrant and pathologic intron retention (IR). IR is not merely a mechanism of gene regulation but may also play a potential role in cancer pathogenesis and therapeutic resistance across various human cancers. Despite its potential significance, there remains a notable gap in comprehensive database resources for introns within tumors. Therefore, we investigated whether the retained introns contain undiscovered protein‐coding ORFs and whether they can encode proteins. We conducted a genome‐wide search for underlying translatable intron ORFs (iORFs) and validated them at the protein level via large‐scale proteomic mass spectrometry (MS) data. Furthermore, we developed the first comprehensive resource, iMPI (an integrative database for MicroProteins encoded by introns), to provide an accessible source of iORF‐encoded microproteins. Our genome‐wide search identified 209,091 introns in the human GRCh38 genome, among which 15,975 were confirmed as candidates with strong coding potential. On the basis of the proteomic MS search, 4751 introns containing a total of 5823 iORFs across 27 cancer types were validated. Detailed annotations, including intron information, coding evidence, subcellular location and structures, were integrated. iMPI is a user‐friendly web interface that is freely available at https://impi.omicsbio.info/ , making it a valuable tool for researchers investigating the spectrum of IR in human cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
- School of Life Sciences, Zhengzhou University, Zhengzhou, China.
Förderung
- National Key R&D Program of China
- Young Talents Program of Sun Yat-sen University Cancer Center
- National Natural Science Foundation of China
- Fostering Fund of Fundamental Research for Young Teachers of Zhengzhou University
- Guangdong Esophageal Cancer Institute Science and Technology Program
- National Key Research and Development Program of China
Zitieren
APA
Hu, J., Zheng, Y., Huang, X., Liang, Z., Di, J., Cao, B., Wang, L., Li, J., Fu, Z., Li, H., Cheng, H., & Liu, Z. X. (2026). iMPI: An Integrative Database for MicroProteins Encoded by Intron Retention in Tumors. PROTEOMICS. https://doi.org/10.1002/pmic.70142
Vancouver
Hu J, Zheng Y, Huang X, Liang Z, Di J, Cao B, et al. iMPI: An Integrative Database for MicroProteins Encoded by Intron Retention in Tumors. PROTEOMICS. 2026. doi:10.1002/pmic.70142
BibTeX
@article{Hu2026,
author = {Hu, Jiamin and Zheng, Yongqiang and Huang, Xin and Liang, Zhuoran and Di, Juntong and Cao, Bijin and Wang, Lulu and Li, Junteng and Fu, Zhe and Li, Hao and Cheng, Han and Liu, Ze-Xian},
title = {iMPI: An Integrative Database for MicroProteins Encoded by Intron Retention in Tumors},
journal = {PROTEOMICS},
year = {2026},
doi = {10.1002/pmic.70142}
}
EUVIMED